FANCA Gene

Last updated on: 08.12.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The FANCA gene (FANCA stands for "FA Complementation Group A") is a protein-coding gene located on chromosome 16q24.3. Alternative splicing results in multiple transcript variants that code for different isoforms.

General informationThis section has been translated automatically.

Mutations in the FANCA gene are associated with Fanconi anemia (OMIM:227650). Fanconi anemia is a rare genetic disorder that follows autosomal recessive inheritance with the exception of FANCB and FANCR. Currently, mutations are known in 22 FA genes, with most patients having mutations in FANCA, FANCC, and FANCG. Loss of function in any of the FA genes leads to increased genetic instability, which can be detected in all cells, especially after administration of DNA double-strand cross-linking agents, such as mitomycin C or diepoxybutane (FA belongs to the so-called chromosome break syndromes).

Clinically, the disease is characterized by progressive pancytopenia, bone marrow insufficiency, various congenital malformations, and a predisposition to the occurrence of hematologic or solid tumors.

LiteratureThis section has been translated automatically.

  1. Abu-Issa et al (1999) Expression of the Fanconi anemia group A gene (Fanca) during mouse embryogenesis. Blood 94: 818-824.
  2. Alter BP et al (2007) Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2. J Med Genet 44: 1-9.
  3. Joenje H et al (2000) Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A. Am J Hum Genet 67: 759-762.

Last updated on: 08.12.2022